PriceTracker GLP-1

Status · Medicare GLP-1 coverage · checked October 2026

Medicare GLP-1 coverage: yes since July 1, 2026, through the GLP-1 Bridge

As of October 2026, Medicare covers Wegovy (injection or tablet), Foundayo and the Zepbound KwikPen for weight loss through the temporary Medicare GLP-1 Bridge, for eligible people with Part D, at a $50 monthly copayment.

Julian CaraulaniFounder, PriceTracker GLP-1Sources read October 2026

Question: Does Medicare cover GLP-1s for weight loss? · Checked October 2026 · Re-checked monthly

Cheapest GLP-1 right now$69/mo at SnagRx, billed monthly. Checked 9 Oct 2026.

$69/mo at SnagRx on SnagRx’s site ↗

Status

ItemStatusSinceSource
Covered drugsFoundayo (tablet), Wegovy (injection or tablet), Zepbound (KwikPen only)Jul 1, 2026Medicare.gov
Who can use itCertain people with Medicare drug coverage (Part D)Jul 1, 2026Medicare.gov
Copayment$50 for a one-month supplyJul 1, 2026Medicare.gov
Prior authorizationValid through Dec 31, 2027, unless you change GLP-1sJul 1, 2026Medicare.gov
Type 2 diabetes, sleep apnea, fatty liverNot in the Bridge; your Part D plan might cover the drugJul 1, 2026Medicare.gov

FDA’s shortage list today

Straight from FDA’s drug shortage database, last updated by FDA in October 2026.

  • semaglutide: being discontinued (Rybelsus).
  • tirzepatide: not on the list.
  • liraglutide: in shortage (Liraglutide, Saxenda, Victoza); being discontinued (Liraglutide, Saxenda).

FDA drug shortage database · read through openFDA · discontinuation is a maker’s decision, not a shortage

In the regulator’s own words

"Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) · Wegovy® (injection or tablet) · Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens)."
Medicare.gov, Weight loss drugs, read October 2026
"You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug)."
Medicare.gov, Weight loss drugs, read October 2026
"Your prior authorization is valid (including for refills and dose changes) through December 31, 2027, unless you change GLP-1s."
Medicare.gov, Weight loss drugs, read October 2026

This page reports what the regulator has published, in its words. It is not legal or medical advice.

Related

Statuses change. Prices change more.

One email a week: the cheapest GLP-1 program and any real price moves.

Compare every GLP-1